Thomson Reuters announces acquisition of Healthcare Data Management

NewsGuard 100/100 Score

Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced that it has acquired Healthcare Data Management, Inc. Effective immediately, the company will become part of the Healthcare & Science business of Thomson Reuters. Financial terms of the transaction were not disclosed.

The acquisition of Healthcare Data Management will enhance current efforts to remove healthcare waste, make cost and quality more transparent, and support the current and future compliance needs of the payer market. Additionally, the acquisition strengthens Thomson Reuters audit and payment integrity capabilities including, but not limited to medical, prescription drug, provider, eligibility, and plan design.

"Healthcare Data Management brings unmatched expertise in health benefits auditing and expense management reporting solutions," said Jon Newpol, executive vice president at the Healthcare & Science business of Thomson Reuters. "Together, we're poised to meet the increased demand for auditing and compliance due to the Sarbanes-Oxley Act, the healthcare reform law, and an overall focus on eliminating waste from the healthcare system.

"Healthcare Data Management's primary solutions, BenefitsAudit and BenefitsWatch, will play a key role in expanding our current solutions for employer and government markets," Newpol said. "As a result, our new Audit & Compliance offering will support both retrospective and ongoing assessments of claims data."

SOURCE Thomson Reuters

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness